#Retrovir

Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.

AZT and ddI were the main drugs associated with liver damage in a new study.

Neither age nor body weight were significantly associated with type 2 diabetes among older people with HIV in a recent study.

Among people with HIV who don’t have hepatitis C virus, various factors raise the risk of liver fibrosis (scarring) and fatty liver disease.

Unlike the World Health Organization’s public health guidelines, these are centered on the individual.

Drug-resistant strains of HIV continue to be transmitted in the UK, but this doesn’t appear likely to have a major effect on the treatment res...

Various HIV antiretrovirals are linked to a raised risk of cardiovascular problems, although the overall risk of such an outcome is still low.

Taking a triple-antiretroviral regimen is best for preventing mother-to-child transmission during pregnancy, rather than taking one drug durin...

Pregnant women who take antiretrovirals (ARVs) to treat HIV early in their pregnancies appear to have a low risk of birth defects in their inf...

The demand for HIV treatment in low- and middle-income nations is projected to rise to 16.8 million people by the close of 2016.

People treated with some of the older versions of a class of HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs) were more...

The prevalence of a sometimes-painful nerve condition called peripheral neuropathy (PN) remains high in people with HIV despite effective anti...

The antiretroviral (ARV) drug tenofovir (found in Viread, Truvada and Atripla) might calm the immune system in people with HIV and make them l...

HIV might damage cellular mitochondria, the suspected cause of face and body fat loss attributed to older antiretroviral (ARV) medications. Th...

People with vitamin D deficiency who switched off efavirenz—found in Sustiva and Atripla—were likely to see improvements in their...